The Role of Thiazolidinediones in the Treatment of Patients with Type 2 Diabetes Mellitus
作者： Arshag D. Mooradian , Joe Chehade , Jerome E. Thurman
DOI: 10.2165/00024677-200201010-00002
关键词: Diabetes mellitus 、 Medicine 、 Metformin 、 Endocrinology 、 Insulin resistance 、 Type 2 Diabetes Mellitus 、 Pharmacy 、 Internal medicine 、 Troglitazone 、 Rosiglitazone 、 Pioglitazone
摘要: Diabetes mellitus is a significant and growing health concern worldwide. Unfortunately, type 2 diabetes generally under-managed, this may explain the increasing prevalence of diabetic complications throughout world. The introduction newer classes antihyperglycemic agents should enhance ability clinicians to achieve optimal blood glucose control.
springer.com
sci-hub.se 参考文章(61)
Tsutomu Takagi, Takashi Akasaka, Atsushi Yamamuro, Yasuhiro Honda, Takeshi Hozumi, Shigefumi Morioka, Kiyoshi Yoshida, Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non–insulin dependent diabetes mellitus: A serial intravascular ultrasound study Journal of the American College of Cardiology. ,vol. 36, pp. 1529- 1535 ,(2000) , 10.1016/S0735-1097(00)00895-0
N. Møller, O. Schmitz, O. Pedersen, A. Saaek, J. F. Bak, In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment. Diabetologia. ,vol. 35, pp. 777- 784 ,(1992) , 10.1007/BF00429100
Nicholas C. Turner, John C. Clapham, Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: Current status and therapeutic possibilities Progress in drug research. ,vol. 51, pp. 33- 94 ,(1998) , 10.1007/978-3-0348-8845-5_2
Charles G. Gegick, MD, FACP, Michael D. Altheimer, MD, FACE, Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice. Endocrine Practice. ,vol. 7, pp. 162- 169 ,(2001) , 10.4158/EP.7.3.162
Claire M. Steppan, Shannon T. Bailey, Savitha Bhat, Elizabeth J. Brown, Ronadip R. Banerjee, Christopher M. Wright, Hiralben R. Patel, Rexford S. Ahima, Mitchell A. Lazar, The hormone resistin links obesity to diabetes Nature. ,vol. 409, pp. 307- 312 ,(2001) , 10.1038/35053000
Jeffrey S. Flier, Diabetes. The missing link with obesity Nature. ,vol. 409, pp. 292- 293 ,(2001) , 10.1038/35053251
D. T. Finegood, M. D. McArthur, D. Kojwang, M. J. Thomas, B. G. Topp, T. Leonard, R. E. Buckingham, Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes. ,vol. 50, pp. 1021- 1029 ,(2001) , 10.2337/DIABETES.50.5.1021
C F Burant, S Sreenan, K Hirano, T A Tai, J Lohmiller, J Lukens, N O Davidson, S Ross, R A Graves, Troglitazone Action Is Independent of Adipose Tissue Journal of Clinical Investigation. ,vol. 100, pp. 2900- 2908 ,(1997) , 10.1172/JCI119839
Robert C Turner, Carole A Cull, Valeria Frighi, Rury R Holman, UK Prospective Diabetes Study (UKPDS) Group, UK Prospective Diabetes Study (UKPDS) Group, None, Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49) JAMA. ,vol. 281, pp. 2005- 2012 ,(1999) , 10.1001/JAMA.281.21.2005
Timothy M. Willson, Peter J. Brown, Daniel D. Sternbach, Brad R. Henke, The PPARs: from orphan receptors to drug discovery. Journal of Medicinal Chemistry. ,vol. 43, pp. 527- 550 ,(2000) , 10.1021/JM990554G